ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Blood clots that form on implanted medical devices such as catheters and heart valves can curtail the lifetimes of the devices and possibly lead to health complications. Antithrombotic agents could prevent such clots, but scientists have yet to find a suitable way to provide a long-lasting, steady supply of those agents. As a possible solution, Teng Xue, Xiangfeng Duan, and Yu Huang of UCLA; Mark E. Meyerhoff of the University of Michigan; and coworkers have developed a catalytic system that generates the antithrombotic agent nitroxyl (HNO) from species commonly found in blood (Nat. Commun. 2014, DOI: 10.1038/ncomms4200). The system consists of the enzyme glucose oxidase and the molecular catalyst hemin, both attached to graphene. Glucose oxidase catalyzes the oxidation of glucose, a reaction that generates a local supply of hydrogen peroxide. Hemin then uses hydrogen peroxide to oxidize
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X